Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
TR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
This study has been completed.
Study NCT01421511 Information provided by Trius Therapeutics, Inc.
First Received on August 19, 2011. Last Updated on December 4, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Interventions listed in this trial
Linezolid for 10 days of treatment
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Molecular Mechanisms of Pharmacological Action
Protein Synthesis Inhibitors
Sponsors listed in this trial
Trius Therapeutics, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers